Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,413.37 -25.28 (-0.30%) Bitcoin USD
66,326.92 -7.70 (-0.01%) CMC Crypto 200
1,398.48 +24.64 (+1.79%)
GSK plc (GSK.L)
| Previous close | 1,783.50 |
| Open | 1,773.50 |
| Bid | 1,775.50 x 0 |
| Ask | 1,776.50 x 0 |
| Day's range | 1,764.50 - 1,779.50 |
| 52-week range | 1,302.60 - 1,821.00 |
| Volume | |
| Avg. volume | 7,803,907 |
| Market cap | 73.635B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 16.30 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.60 (3.36%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
- Evening Standard
FTSE 100 Live 17 May: LandSec shares fall on results, GSK in £1.25bn final Haleon stake sale
GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results. The sale of GSK’s remaining 4% stake raised £1.25 billion, having held 13% following its 2022 demerger of the Panadol and Sensodyne business. Land Securities revealed a smaller full-year loss of £341 million amid “robust” rental growth across its estate.
- Yahoo Finance UK
Trending tickers: Tesla, Reddit, Walmart and GSK
The latest investor updates on stocks that are trending on Friday.
- GuruFocus.com
GSK PLC's Dividend Analysis
GSK PLC (NYSE:GSK) recently announced a dividend of $0.38 per share, payable on July 11, 2024, with the ex-dividend date set for May 16, 2024. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Utilizing the data from GuruFocus, let's delve into GSK PLC's dividend performance and assess its sustainability.
